Global Therapeutic Vaccines Market will reach USD 47.44 Billion by 2022: Zion Market Research

Sarasota, FL, March 03, 2017 (GLOBE NEWSWIRE) -- Zion Market Research has published a new report titled “Therapeutic Vaccines Market by Products (Addiction Vaccines, Autoimmune Disease Vaccines, Infectious Disease Vaccines and Neurological Disease Vaccines) and by Technology (Autologous Vaccine and Allogeneic Vaccine): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2016 - 2022”

According to the report, global therapeutic vaccines market was valued at approximately USD 10.54 billion in 2016 and is expected to generate revenue of around USD 47.44 billion by end of 2022, growing at a CAGR of around 28.5% between 2017 and 2022. 

Vaccines are biological preparations that assist in acquiring immunity to a particular antigen or disease. Vaccine mimics the structure of antigen so as to generate immune response to destroy the foreign material and also keep the memory of it to fight against future invasion. Vaccines are mainly of two types: prophylactic vaccines and therapeutic vaccines. Prophylactic vaccines are used to prevent infection wherein therapeutic vaccines are used to treat the disease. Therapeutic vaccines are gaining importance owing to their immunogenic specificity for individual infective disease agents. Therapeutic vaccines are currently developed for chronic viral infections, such as human papillomavirus (HPV), human immunodeficiency virus (HIV), herpesvirus and hepatitis B (HBV) and C (HCV) virus infections, cancer etc. as an alternative to antiviral treatment.  

Browse through 27 Market Tables and 16 Figures spread through 110 Pages and in-depth TOC on “Global Therapeutic Vaccines Market: By Product, Technology, Type, Size, Share, Analysis, Segment and Forecast 2016 – 2022”.

Request Free Sample copy of Therapeutic Vaccines Market Report @ https://www.zionmarketresearch.com/sample/therapeutic-vaccines-market

Global therapeutic vaccines market is primarily driven by growing incidences of chronic diseases such as cancer, HIV etc. across the globe. Other major driving factors are increasing funds from the government for research and development of vaccines coupled with technological advancements. However, high treatment cost and stringent regulatory policies coupled with high initial capital investment are the major restraints that may limit the growth of the market. Nonetheless increasing focus on personalized medicine coupled along with the need for effective treatment are likely to disclose the new avenues for therapeutic vaccines market in the near future.

The therapeutic vaccines market is segmented on the basis of product type segment as addiction vaccines, autoimmune disease vaccines, infectious disease vaccines and neurological disease vaccines. Autoimmune disease vaccine segment is expected to grow at fastest rate in the global market over the forecast period. The therapeutic vaccines market is segmented based on technology into autologous vaccines and allogeneic vaccines. 

Browse the full "Therapeutic Vaccines Market by Products (Addiction Vaccines, Autoimmune Disease Vaccines, Infectious Disease Vaccines and Neurological Disease Vaccines) and by Technology (Autologous Vaccine and Allogeneic Vaccine): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2016 - 2022" report at https://www.zionmarketresearch.com/report/therapeutic-vaccines-market

North America represents developed regional markets for therapeutic vaccines and is expected to see the rapid growth in the years to come. The U.S. is by far the leading therapeutic vaccine market by country in North America. The U.S. market is expected to grow at the highest CAGR during the forecast period. This growth is mainly due to the well-developed healthcare infrastructure and increases in research and development on a therapeutic vaccine. Moreover, the disposable income and reimbursement of life-threatening diseases are very high in this region which promotes the growth of therapeutic vaccine market. 

Europe was the second largest regional market and is expected to show significant growth in the years to come. This growth is mainly due to increase in a number of patients diagnosed with cancer.

Inquire more about this report @ https://www.zionmarketresearch.com/inquiry/therapeutic-vaccines-market

Asia-Pacific is expected to witness noticeable growth in the near future. In Asia, China, India, and Japan will continue to be the fastest growing markets in therapeutic vaccine market. Growth in Asia-Pacific market is expected to be driven by increasing geriatric population base with increased prevalence of cancer.

In Middle East & Africa; African region is projected to register moderate growth rate due to the high cost of therapeutic vaccines. Latin America is another important regional market and is expected to experience moderate growth over the forecast period. Thus, all the aforementioned parameters are expected to propel the market growth in this region.

Request customized copy of report @ https://www.zionmarketresearch.com/custom/1220

Some of the key players in therapeutic vaccines market include Valeant Pharmaceuticals, BioVex, Inc., Inovio Pharmaceuticals, Inc., Immunocellular Therapeutics, Ltd., Agenus Inc., GlaxoSmithKline plc., Pfizer Inc., Novartis AG, Argos Therapeutics, Bavarian Nordic, Transgene, Galena Biopharma and Vaccinogen, Inc. among others.

This report segments the global therapeutic vaccines market as follows:

Global Therapeutic vaccines Market: Product Segment Analysis

  • Addiction Vaccines
  • Autoimmune Disease Vaccines
  • Infectious Disease Vaccines
  • Neurological Disease Vaccines

Global Therapeutic Vaccines Market: Technology Segment Analysis

  • Autologous vaccines 
  • Allogeneic vaccines

Global Therapeutic Vaccines Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

Related Reports:

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Follow Us LinkedIn: https://www.linkedin.com/company/zion-market-research

Follow Us Twitter: https://twitter.com/zion_research

CONTACT: 
Contact Us:

Joel John

4283, Express Lane, Suite 634-143,
Sarasota, Florida 34249, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com

Ads